Drug Report History #213098
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v20-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated (Changed) | Updated to: 2024-07-02 | Was: 2023-12-12 |
| Drug Identification Number | 02193221 | 02193221 |
| Brand name | THIAMIJECT INJECTION - LIQ IM IV 100MG/ML | THIAMIJECT INJECTION - LIQ IM IV 100MG/ML |
| Common or Proper name | Thiamine Hydrochloride Injection USP | Thiamine Hydrochloride Injection USP |
| Company Name | OMEGA LABORATORIES LIMITED | OMEGA LABORATORIES LIMITED |
| Ingredients | THIAMINE HYDROCHLORIDE | THIAMINE HYDROCHLORIDE |
| Strength(s) | 100MG | 100MG |
| Dosage form(s) | LIQUID | LIQUID |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 5 x 10mL vial / fiole | 5 x 10mL vial / fiole |
| Additional packaging sizes | ||
| ATC code | A11DA | A11DA |
| ATC description | VIT B1,PLAIN AND IN COMB WITH VITAMIN B6 AND B12 | VIT B1,PLAIN AND IN COMB WITH VITAMIN B6 AND B12 |
| Reason for shortage (Changed) | Updated to: Disruption of the manufacture of the drug. | Was: Demand increase for the drug. |
| Anticipated start date (Changed) | Updated to: | Was: 2023-12-19 |
| Actual start date (Changed) | Updated to: 2023-12-19 | Was: |
| Estimated end date (Changed) | Updated to: 2024-07-02 | Was: 2024-01-12 |
| Actual end date (Changed) | Updated to: 2024-07-02 | Was: |
| Shortage status (Changed) | Updated to: Actual shortage | Was: Anticipated shortage |
| Tier 3 Status (Changed) | Updated to: Yes | Was: No |
| Company comments (Changed) | Updated to: Product on allocation starting mid-April 2024 | Was: |
| Health Canada comments |